ArticleAdvances in cell and gene therapy2018

Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.

Karlo Perica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.